Search research articles
Contact Us
Filters
Showing results (1-10 of 148) with videos related to
Page
of 15
Sort By:
Digestive Diseases (Basel, Switzerland)
|
November 10, 2009
Major advances in our knowledge of the etiology and pathogenesis of inflammatory diseases of the gastrointestinal tract. Preface
Martin Zeitz
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
Pralnacasan (vertex pharmaceuticals)
Britta Siegmund, Martin Zeitz
Langenbeck'S Archives of Surgery
|
April 12, 2011
Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations
Jochen Maul, Martin Zeitz
European Journal of Immunology
|
August 13, 2009
Clinical aspects of inflammatory bowel disease
Britta Siegmund, Martin Zeitz
World Journal of Gastroenterology
|
September 14, 2011
Innate and adaptive immunity in inflammatory bowel disease
Britta Siegmund, Martin Zeitz
The New England Journal of Medicine
|
March 30, 2004
Esophageal cancer
Hans Scherübl, Martin Zeitz
Langenbeck'S Archives of Surgery
|
September 28, 2004
Standards of medical treatment and nutrition in Crohn's disease
Britta Siegmund, Martin Zeitz
Annals of Nutrition & Metabolism
|
September 11, 2010
Scientific evidence for the medical use of probiotics
Stephan C Bischoff, Martin Zeitz
Best Practice & Research. Clinical Gastroenterology
|
April 30, 2002
Small bowel disease in the elderly: diarrhoea and malabsorption
Jörg C Hoffmann, Martin Zeitz
Medizinische Klinik (Munich, Germany : 1983)
|
January 18, 2005
[S3 guideline by the German Society of Digestive and Metabolic Diseases and the Competence Network of Chronic Inflammatory Bowel diseases on diagnosis and therapy of ulcerative colitis. An update]
Jörg C Hoffmann, Martin Zeitz,
Page
of 15
Search research articles
Search
Showing results (1-10 of 148) with videos related to
Sort By:
Page
of 15
Digestive Diseases (Basel, Switzerland)
|
November 10, 2009
Major advances in our knowledge of the etiology and pathogenesis of inflammatory diseases of the gastrointestinal tract. Preface
Martin Zeitz
Idrugs : the Investigational Drugs Journal
|
June 6, 2003
Pralnacasan (vertex pharmaceuticals)
Britta Siegmund, Martin Zeitz
Langenbeck'S Archives of Surgery
|
April 12, 2011
Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations
Jochen Maul, Martin Zeitz
European Journal of Immunology
|
August 13, 2009
Clinical aspects of inflammatory bowel disease
Britta Siegmund, Martin Zeitz
World Journal of Gastroenterology
|
September 14, 2011
Innate and adaptive immunity in inflammatory bowel disease
Britta Siegmund, Martin Zeitz
The New England Journal of Medicine
|
March 30, 2004
Esophageal cancer
Hans Scherübl, Martin Zeitz
Langenbeck'S Archives of Surgery
|
September 28, 2004
Standards of medical treatment and nutrition in Crohn's disease
Britta Siegmund, Martin Zeitz
Annals of Nutrition & Metabolism
|
September 11, 2010
Scientific evidence for the medical use of probiotics
Stephan C Bischoff, Martin Zeitz
Best Practice & Research. Clinical Gastroenterology
|
April 30, 2002
Small bowel disease in the elderly: diarrhoea and malabsorption
Jörg C Hoffmann, Martin Zeitz
Medizinische Klinik (Munich, Germany : 1983)
|
January 18, 2005
[S3 guideline by the German Society of Digestive and Metabolic Diseases and the Competence Network of Chronic Inflammatory Bowel diseases on diagnosis and therapy of ulcerative colitis. An update]
Jörg C Hoffmann, Martin Zeitz,
Page
of 15